Main page content

Displaying results 1 - 8 of 8
Publication ID: PEP20-02-01-020
Published:

Based on Treatment Improvement Protocol (TIP) 41, Substance Abuse Treatment: Group Therapy, this Advisory provides an overview of goals, processes, group-specific approaches, resources, and common elements that support favorable outcomes in group therapy.

Publication ID: PEP20-02-02-015
Published:

This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

Publication ID: SMA16-4585KHMER
Published:

Lists questions consumers can ask themselves to help them decide whether to seek help for a substance abuse problem, a mental health issue, or both. Urges those who answered "yes" to any of the questions to seek help and lists resources for more information.

Publication ID: SMA15-3991
Published:

This guide helps counselors improve their skills in leading group therapy sessions for substance use treatment. The guide discusses types of group therapy, confidentiality, client placement, group development, stages of treatment, how-to tips, training, and supervision.

Publication ID: SMA15-4024
Published:

These guidelines are for clinicians who lead group therapy sessions for substance use disorder treatment. It describes types of group therapy, and advantages of group therapy. The guide also provides client placement criteria, and techniques for group development and leadership.

Publication ID: SMA13-4380
Published:

This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.

Publication ID: SMA12-4700
Published:

This manual offers guidance and tools for identifying mental illness or substance use issues early in children and adolescents in various setting, such as in schools, the juvenile justice and child welfare system, and when receiving primary care.

Publication ID: SMA10-4542
Published:

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.